ENTITY
BBI Life Sciences

BBI Life Sciences (1035 HK)

3
Analysis
Health CareHong Kong
BBI Life Sciences Corporation operates in the life sciences research products and services industry. The Company's products and services are applied to DNA synthesis, genetic engineering, life sciences research consumables, and protein and antibody related products and services. BBI serves universities, research institutions, hospitals, pharmaceutical companies, and the government.
more
Refresh
30 Apr 2020 10:28

(Mostly) Asia M&A: April 2020 Roundup

For the month of April, just six new deals were discussed on Smartkarma with an overall announced deal size of ~US$9.4bn. Clicking on the...

Logo
535 Views
Share
20 Apr 2020 12:47

BBI Life: Scheme Doc Out, IFA Ekes Out A Fair Opinion

Back on the 20 January, BBI Life Sciences (1035 HK), the largest supplier of DNA synthesis products in the PRC, announced a privatisation Offer by...

Logo
321 Views
Share
22 Jan 2020 12:39

BBI Life: Privatisation Offer For DNA Synthesizer

Following a brief trading halt, BBI Life Sciences (1035 HK), the biggest supplier of DNA synthesis products in the PRC, announced a privatisation...

Logo
576 Views
Share
No more insights
x